Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Week in Review: An expensive decision | RDN eligibility | FDA approves 3-in-1 polypill | A new recall | ACC backs AMA resolution

News You Need to Know Today
Week in Review: An expensive decision | RDN eligibility | FDA approves 3-in-1 polypill | A new recall | ACC backs AMA resolution
Saturday, June 14, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

This Week’s News

Judge triples damages in antitrust lawsuit, ordering Johnson & Johnson MedTech to pay $442M

A bad outcome for Johnson & Johnson MedTech just got worse. A jury previously ordered the company to pay $147M, but the new total is $442M.

READ MORE >
court judge gavel business man bankruptcy lawsuit
Share on Twitter Share on Facebook Share on Linkedin

Judge triples damages in antitrust lawsuit, ordering Johnson & Johnson MedTech to pay $442M

Share on Twitter Share on Facebook Share on Linkedin
court judge gavel business man bankruptcy lawsuit
A bad outcome for Johnson & Johnson MedTech just got worse. A jury previously ordered the company to pay $147M, but the new total is $442M.
READ MORE >

Study finds 35 million patients may be eligible for renal denervation

However, eligibility alone does not mean a patient will benefit from treatment.

READ MORE >
The Recor Medical renal denervation (RDN) system, pictured here at TCT 2024, and Medtronic’s Symplicity Spyral RDN system have received transitional pass-through payments from CMS for 2025.
Share on Twitter Share on Facebook Share on Linkedin

Study finds 35 million patients may be eligible for renal denervation

Share on Twitter Share on Facebook Share on Linkedin
The Recor Medical renal denervation (RDN) system, pictured here at TCT 2024, and Medtronic’s Symplicity Spyral RDN system have received transitional pass-through payments from CMS for 2025.
However, eligibility alone does not mean a patient will benefit from treatment.
READ MORE >

FDA approves 3-in-1 polypill for hypertension

Widaplik, the new polypill from George Medicines, includes telmisartan, amlodipine and indapamide. The FDA's decision comes after positive data were published in both JACC and The Lancet.

READ MORE >
cardiologist doctor physician patient black diverse hypertension
Share on Twitter Share on Facebook Share on Linkedin

FDA approves 3-in-1 polypill for hypertension

Share on Twitter Share on Facebook Share on Linkedin
cardiologist doctor physician patient black diverse hypertension
Widaplik, the new polypill from George Medicines, includes telmisartan, amlodipine and indapamide. The FDA's decision comes after positive data were published in both JACC and The Lancet.
READ MORE >

GE HealthCare recalls legacy cardiology information systems due to security risk

GE HealthCare has warned that the devices could potentially be accessed and manipulated by an outside party. The FDA has classified this as a Class II recall. 

READ MORE >
the words "FDA recall" on a board
Share on Twitter Share on Facebook Share on Linkedin

GE HealthCare recalls legacy cardiology information systems due to security risk

Share on Twitter Share on Facebook Share on Linkedin
the words "FDA recall" on a board
GE HealthCare has warned that the devices could potentially be accessed and manipulated by an outside party. The FDA has classified this as a Class II recall. 
READ MORE >

AFib ablation during CABG improves survival

Clinical guidelines already recommend that these procedures be performed together when applicable. However, researchers noted, it is still not terribly common among today’s surgeons. 

READ MORE >
CABG coronary artery bypass grafting heart surgery
Share on Twitter Share on Facebook Share on Linkedin

AFib ablation during CABG improves survival

Share on Twitter Share on Facebook Share on Linkedin
CABG coronary artery bypass grafting heart surgery
Clinical guidelines already recommend that these procedures be performed together when applicable. However, researchers noted, it is still not terribly common among today’s surgeons. 
READ MORE >

Cardiac imaging pioneer remembered for his joy and enthusiasm

Former American Society of Echocardiography president and well-known cardiac ultrasound pioneer Roberto Lang, MD, died at the age of 73. He helped develop 3D echo technology that is now used by care teams on a daily basis.

READ MORE >
Roberto Lang speaking at ASE23 on AI industry partnerships.
Share on Twitter Share on Facebook Share on Linkedin

Cardiac imaging pioneer remembered for his joy and enthusiasm

Share on Twitter Share on Facebook Share on Linkedin
Roberto Lang speaking at ASE23 on AI industry partnerships.
Former American Society of Echocardiography president and well-known cardiac ultrasound pioneer Roberto Lang, MD, died at the age of 73. He helped develop 3D echo technology that is now used by care teams on a daily basis.
READ MORE >

ACC backs AMA resolution to boost lung cancer and heart disease screenings in smokers with low-dose CT scans

Former American College of Cardiology president Kim Allan Williams, Sr., MD, an ACC delegate to the American Medical Association House of Delegates, discusses an AMA resolution aimed at improving public awareness of low-dose CT lung cancer exams that can screen for coronary artery calcium at the same time. 

READ MORE >
Former American College of Cardiology (ACC) president Kim Allan Williams, Sr., MD, MACC, MASNC, FAHA, FESC, chair, department of medicine, University of Louisville School of Medicine, and an ACC delegate to the American Medical Association House of Delegates, discusses AMA Resolution 404 aimed at improving public awareness of low-dose CT lung cancer screening that can also identify coronary artery disease (CAD) ate the same time.
Share on Twitter Share on Facebook Share on Linkedin

ACC backs AMA resolution to boost lung cancer and heart disease screenings in smokers with low-dose CT scans

Share on Twitter Share on Facebook Share on Linkedin
Former American College of Cardiology (ACC) president Kim Allan Williams, Sr., MD, MACC, MASNC, FAHA, FESC, chair, department of medicine, University of Louisville School of Medicine, and an ACC delegate to the American Medical Association House of Delegates, discusses AMA Resolution 404 aimed at improving public awareness of low-dose CT lung cancer screening that can also identify coronary artery disease (CAD) ate the same time.
Former American College of Cardiology president Kim Allan Williams, Sr., MD, an ACC delegate to the American Medical Association House of Delegates, discusses an AMA resolution aimed at improving public awareness of low-dose CT lung cancer exams that can screen for coronary artery calcium at the same time. 
READ MORE >

A closer look at GE HealthCare's new affordable cardiac CT scanner

As cardiac CT continues to get used more and more, GE HealthCare has launched a new scanner designed to meet the needs of both outpatient imaging centers and larger hospitals. 

READ MORE >
Ty Bode, senior director of strategy at GE Healthcare, explains the details of a new, economical cardiac CT scanner GE Healthcare launched at the American College of Cardiology (ACC) 2025 meeting. The Revolution Vibe is designed specifically for coronary CT angiography (CCTA), but at a lower price point than the traditional high-end, flagship scanner that have traditional performed CCTA work.
Share on Twitter Share on Facebook Share on Linkedin

A closer look at GE HealthCare's new affordable cardiac CT scanner

Share on Twitter Share on Facebook Share on Linkedin
Ty Bode, senior director of strategy at GE Healthcare, explains the details of a new, economical cardiac CT scanner GE Healthcare launched at the American College of Cardiology (ACC) 2025 meeting. The Revolution Vibe is designed specifically for coronary CT angiography (CCTA), but at a lower price point than the traditional high-end, flagship scanner that have traditional performed CCTA work.
As cardiac CT continues to get used more and more, GE HealthCare has launched a new scanner designed to meet the needs of both outpatient imaging centers and larger hospitals. 
READ MORE >

FastWave Medical reports first-in-human coronary laser IVL procedures

Sola is a rupture-resistant balloon catheter that uses laser energy to deliver 360-degree pressure with each pulse. It was designed to address limitations the company saw in current calcium-modification devices.

READ MORE >
The Fastwave Sola laser IVL system energy burst to break up coronary calcium.
Share on Twitter Share on Facebook Share on Linkedin

FastWave Medical reports first-in-human coronary laser IVL procedures

Share on Twitter Share on Facebook Share on Linkedin
The Fastwave Sola laser IVL system energy burst to break up coronary calcium.
Sola is a rupture-resistant balloon catheter that uses laser energy to deliver 360-degree pressure with each pulse. It was designed to address limitations the company saw in current calcium-modification devices.
READ MORE >

Balloon-expandable, self-expanding TAVR valves associated with comparable long-term outcomes

Patients treated with the Sapien 3 platform from Edwards Lifesciences and the Evolut platform from Medtronic were linked to more similarities than differences after six years. This was a single-center study, researchers noted, but it does provide an in-depth look at the safety and effectiveness of TAVR.

READ MORE >
cardiologists heart doctors heart research heart data
Share on Twitter Share on Facebook Share on Linkedin

Balloon-expandable, self-expanding TAVR valves associated with comparable long-term outcomes

Share on Twitter Share on Facebook Share on Linkedin
cardiologists heart doctors heart research heart data
Patients treated with the Sapien 3 platform from Edwards Lifesciences and the Evolut platform from Medtronic were linked to more similarities than differences after six years. This was a single-center study, researchers noted, but it does provide an in-depth look at the safety and effectiveness of TAVR.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Surgery outperforms GLP-1 drugs | CEPDs fail to make an impact | Redo TAVR: Supra-annular vs. intra-annular valves
Week in Review: FDA clears imaging platform | Vascular device linked to deaths | GLP-1 drugs & AFib | Pacemakers recalled again
Optimism about cardiology’s future | HRS leader looks ahead | Women live longer after TAVR | J&J announces acquisition
Preventing the most common complication after heart surgery | When bioprosthetic valves fail | Good news for Medtronic
PFA's dominance & other key EP trends | FDA approves next-gen mitral valve | Virtual nursing helps practices combat burnout
FDA's new device warning | How to implement AI-powered coronary plaque software | Key approvals for Abbott | IV fluids recalled
New SCAI president outlines focus into 2027 | DCBs have similar outcomes to DES | GLP-1s lower AFib

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …6
    • Page 7
    • Page 8
    • Page 9
    • Current page 10
    • Page 11
    • Page 12
    • Page 13
    • Page 14 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup